Nektar Therapeutics (NKTR) vs Omeros Corporation (OMER)
- Nektar Therapeutics NKTR 35.78 −5.14%
- Omeros Corporation OMER 16.20 −13.78%
Nektar Therapeutics and Omeros Corporation are both Biotechnology companies. Nektar Therapeutics and Omeros Corporation are of similar size ($1.4B and $1.3B). Nektar Therapeutics has negative trailing earnings, so its P/E is not meaningful; Omeros Corporation trades at 9.5×. Omeros Corporation grew revenue faster over the last twelve months: 36.3% against −27.2%. Omeros Corporation has the higher net margin (128.4% vs −287.8%) and the higher return on invested capital (0.00% vs −40.2%). Across the 17 metrics below, Omeros Corporation leads on 14 and Nektar Therapeutics on 3.
Valuation
Profitability
| Metric | NKTR | OMER | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 37.57% | 65.16% |
| Operating margin | (257.80%) | (74.88%) | 0.00% |
| Net margin | (287.84%) | 128.36% | 0.00% |
| Free cash flow margin | (428.72%) | (70.69%) | 0.00% |
| Return on equity | (35.75%) | (89.15%) | (56.36%) |
| Return on assets | (24.12%) | 51.22% | (48.04%) |
| Return on invested capital | (40.20%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack